Post Marketing Surveillance of Effectiveness (All-Cause Mortality) of Posaconazole Injection and Tablet Treatment of Invasive Aspergillosis in Chinese patients (MK-5592-141)

18/01/2024
22/07/2025
EU PAS number:
EUPAS108481
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

MK-5592-141-00-v1-Protocol_final-redaction

English (771.06 KB - PDF) View document
Updated protocol

MK-5592-141-01-v1-Protocol_final-redaction.pdf

First published: 09/01/2025
English (1.74 MB - PDF) View document
Study results
Study results

MK-5592-P141 CSR_final-redaction.pdf

English (766.32 KB - PDF) View document
Study report
Other information